Radium-223 in Metastatic Castration-Resistant Prostate Cancer: Single-Institution Analysis of Factors Associated With Treatment Completion and Survival

被引：0
|
作者：
Bang, A. [1 ]
Malone, S. [1 ]
Leung, E. Y. C. [2 ]
Canil, C. [1 ]
Eapen, L. [1 ]
Morgan, S. C. [1 ]
机构：
[1] Ottawa Hosp, Ctr Canc, Ottawa, ON, Canada
[2] Ottawa Hosp, Ottawa, ON, Canada
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2016年 / 96卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2016.06.1276
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2633
引用
收藏
页码：E260 / E261
页数：2
相关论文
共 50 条
  • [1] RADIUM-223 IN METASTATIC CASTRATION- RESISTANT PROSTATE CANCER: SINGLE-INSTITUTION ANALYSIS OF FACTORS ASSOCIATED WITH TREATMENT COMPLETION AND SURVIVAL
    Bang, Andrew
    Malone, Shawn
    Leung, Eugene
    Canil, Christina
    Eapen, Libni
    Morgan, Scott
    RADIOTHERAPY AND ONCOLOGY, 2016, 120 : S81 - S81
  • [2] Factors Associated With Survival Following Radium-223 Treatment for Metastatic Castration-resistant Prostate Cancer
    Wong, William W.
    Anderson, Eric M.
    Mohammadi, Homan
    Daniels, Thomas B.
    Schild, Steve E.
    Keole, Sameer R.
    Choo, C. Richard
    Tzou, Katherine S.
    Bryce, Alan H.
    Ho, Thai H.
    Quevedo, Fernando J.
    Vora, Sujay A.
    CLINICAL GENITOURINARY CANCER, 2017, 15 (06) : E969 - E975
  • [3] Radium-223 In The Treatment Of Metastatic Castration-Resistant Prostate Cancer
    Vazzana, C.
    Morano, S.
    Di Lascio, A.
    Grana, C.
    Chinol, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S880 - S880
  • [4] Predictors for Survival After Radium-223 Treatment for Castration-Resistant Metastatic Prostate Cancer
    Anderson, E.
    Wong, W. W.
    Mohammadi, H.
    Daniels, T. B.
    Vora, S.
    Schild, S. E.
    Keole, S. R.
    Choo, C. R.
    Tzou, K. S.
    Bryce, A.
    Ho, T. H.
    Quevedo, F. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E255 - E255
  • [5] Radium-223 for the treatment of castration-resistant prostate cancer
    El-Amm, Joelle
    Aragon-Ching, Jeanny B.
    ONCOTARGETS AND THERAPY, 2015, 8 : 1103 - 1109
  • [6] RADIUM-223: TREATING METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
    James, D.
    Hillery, R.
    Freeman, L.
    Kumari, A.
    Kearney, N.
    INTERNAL MEDICINE JOURNAL, 2016, 46 : 30 - 31
  • [7] Practical recommendations for radium-223 treatment of metastatic castration-resistant prostate cancer
    Yong Du
    Ignasi Carrio
    Giuseppe De Vincentis
    Stefano Fanti
    Harun Ilhan
    Caroline Mommsen
    Egbert Nitzsche
    Francis Sundram
    Wouter Vogel
    Wim Oyen
    Val Lewington
    European Journal of Nuclear Medicine and Molecular Imaging, 2017, 44 : 1671 - 1678
  • [8] Radium-223 for the treatment of metastatic castration-resistant prostate cancer: A window of opportunity
    Gomez-Veiga, F.
    Alvarez-Ossorio, J. L.
    Carballido-Rodriguez, J.
    Juarez-Soto, A.
    Rodriguez-Antolin, A.
    Cozar-Olmo, J. M.
    ACTAS UROLOGICAS ESPANOLAS, 2018, 42 (10): : 616 - 624
  • [9] Practical recommendations for radium-223 treatment of metastatic castration-resistant prostate cancer
    Du, Yong
    Carrio, Ignasi
    De Vincentis, Giuseppe
    Fanti, Stefano
    Ilhan, Harun
    Mommsen, Caroline
    Nitzsche, Egbert
    Sundram, Francis
    Vogel, Wouter
    Oyen, Wim
    Lewington, Val
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (10) : 1671 - 1678
  • [10] Overall survival prediction in metastatic castration-resistant prostate cancer treated with radium-223
    Vidal, Monica
    Delgado, Alejandro
    Martinez, Carlos
    Jaime Correa, Jose
    Cristina Durango, Isabel
    INTERNATIONAL BRAZ J UROL, 2020, 46 (04): : 599 - 611
12345